A STUDY OF FOUR DOSING REGIMENS OF PROCRIT (EPOETIN ALFA) IN PATIENTS WITH CHRONIC KIDNEY DISEASE. PROTOCOL ADDENDUM: EXTENSION STUDY OF MAINTENANCE THERAPY OF PROCRIT (EPOETIN ALFA) IN PATIENTS WITH CHRONIC KIDNEY DISEASE.: